Regulatory work by the Trump HHS is continuing full speed in the aftermath of the election, with the surprise reappearance of a once-scrapped rule to ban Medicare drug rebates, finalization of the Medicaid managed care rule and the White House budget office’s recent clearance of FDA guidance and a Substance Abuse and Mental Health Services regulation. The full-speed-ahead mode has key congressional Democrats worried that the Trump administration will try to roll back health protections before leaving office. OMB is...